1. Unat EK, Yücel A. Tıp mikolojisi. Unat E, Yü-
cel A, Altaş K, Samastı M. Unatın Tıp Parazi-
İnsanın ökaryonlu parazitleri ve bunlarla
bulaşan hastalıklarında. Beşinci baskı.
İstanbul, Cerrahpaşa Tıp Fak. Vakfı Yayınları;
No. 15; 1995; 831-839.
2. Ghannoum MA, Abu Elteen KH. Pathogenicity
determinants of Candida. Mycoses 1990; 33:
265-282.
3. Kwon-Chung KJ, Bennett JE. Medical Mycology.
Philadelphia, Lea and Febinger, 1992; 280-
336.
4. Douglas JL. The surface layers of Candida albicans
and their relevance to pathogenicity. In:
Surface Structures of Microorganisms and
Their Interactions with the Mammalian Host.
(Eds) Schrinner E, Richmond MH, Seibert G,
Schwarz U. Weinheim, VCH Verlagsgelleschaft
mbH, 1988; 155-163.
5. Segal E, Soroka A, Schechter A. Correlative
relationship between adherence of Candida albicans
to human vaginal epithelial cells in vitro
and candidal vaginitis. Sabouradia 1984; 22:
191-200.
6. Ghannoum MA, Abu El-Teen K, Radwan SS.
Blocking adherence of Candida albicans to buccal
epithelial cells by yeast glycolipids, yeast
wall lipids and lipids from epithelial cells.
Mykosen 1987; 30: 371-378.
7. Wellmer A, Bernhardt H. Adherence on buccal
epithelial cells and germ tube formation in the
continious flow culture of clinical Candida albicans
izolates. Mycoses 1997; 40: 363-368.
8. Yücel A, Kantarcõoğlu AS. Mantarlarda dimorfizm.
(İnfeksiyon Dergisine sunulmuştur).
9. Sobel JD, Muller G, Buckley HR. Critical role
of germ tube formation in the pathogenesis of
Candida vaginitis. Infect Immun 1984; 44: 576-
580.
10. Baillie GS, Douglas LJ. Role of dimorphism in
the development of Candida albicans biofilms.
J Med Microbiol 1999; 48: 671-679.
11. Rüchel R, Tegeler R, Trost M. A comparison of
secretory proteinase from different strains of C.
albicans. Sabouradia 1982; 20: 233-244.
12. Samaranayake LP, Hughes A, MacFarlane TW.
The proteolytic potential of Candida albicans in
human saliva supplemented with glucose. J
Med Microbiol 1984; 17: 13-22.
13. Ghannoum MA, Abu-Elteen K.Correlative relationship
between proteinase production, adherence
and pathogenicity of various strains of C.
albicans. J Med Vet Mycol 1986; 24: 407-413.
14. Borg M, Rüchel R. Expression of extracellular
acid proteinase by proteolytic Candida spp during
experimental infection of oral mucosa. Infect
Immun 1988; 56: 626-631.
15. Edison MA, Manning-Zweering M. Comparison
of the extracellular proteinase activity produced
by a low virulence mutant of Candida
albicans and its wild type parent. Infect Immun
1988; 56: 1388-1390.
16. Kõlõç N, Kuştimur S, Arslan S, Aldemir H.
Fluorometric determination of acid proteinase
activity in vulvovaginal candidosis. Mycoses
1996; 39: 347-351.
17. Kuştimur S. Candidada virulans faktörleri. I.
Ulusal Mantar Hastalıkları ve Klinik Mikrobiyoloji
Kongresi (4-6 Mayõs 1999, İzmir). Tutanaklar
1999; 145-150.
18. Schaller M, Korting HC, Felk A, Hess D,
Schafer W, Hube B. Attenuated virulence of
different SAP (secretory aspartyl proteinase)
null mutants in an in vitro model of human
oral candidosis. 5th Congress of the European
Confederation of Medical Mycology (June 3-6
1999, Dresden, Germany). Abstracts. Mycoses
1999; 42: 157.
19. Wu T, Samaranayake P. The expression of secreted
aspartyl proteinases of Candida species
in human whole saliva. J Med Microbiol 1999;
48: 711-720.
20. Kretschmar M. Murine model of Candida peritonitis.
5th Congress of the European Confederation
of Medical Mycology (June 3-6 1999,
Dresden, Germany). Abstracts. Mycoses 1999;
42: 141-142.
21. Borg-von Zepelin M, Meyer I, Sanglard D,
Monod M. Inhibition of secreted aspartic Candida
proteinases and reduction of adherens of
Candida strains by different HIV proteinase
inhibitors. 5th Congress of the European Confederation
of Medical Mycology (June 3-6 1999,
Dresden, Germany). Abstracts. Mycoses 1999;
42: 127-128.
22. De Bernardis F, Mondello F, Scaravelli G, Pachi
A, Girolamo A, Agatensi L, Cassone A. High
aspartyl proteinase production and vaginitis in
human immunodefficiency virus-infected
women. J Clin Microbiol 1999; 37: 1376-1380.
23. Rüchel R, Böning B, Borg M. Characterization
of a secretory proteinase of Candida parapsilosis
and evidence for the absence of the enzyme
during infection in vitro. Infect Immun 1986;
53: 411-419.
24. Banno Y, Yamada T, Nozawa Y. Secreted phospholipases
of the dimorphic fungus Candida
albicans, separation of three enzymes and some
biological properties. J Med Vet Mycol 1985; 23:
47-54.
CANDIDADA VİRÜLENS FAKTTemmuz-Eylül 2000 ÖRLERİ; YÜCEL VE KANTARCIOĞLU 185
25. Price MF, Cawson RA. Phospholipase activity
in Candida albicans. Sabouradia 1977; 15: 179-
185.
26. Hube B, Schaller M, Bossenz M, Mazur A, Heb
D, Felk A, Malz S, Schafer W. Molecular approaches
to study virulence attributes in Candida
albicans. 5th Congress of the European
Confederation of Medical Mycology (June 3-6
1999, Dresden, Germany). Abstracts. Mycoses
1999; 42: 137-138.
27. Sandin RL, Rogers AL, Patterson RJ, Beneke
ES. Evidence for mannose-mediated adherence
of Candida albicans to human buccal cells in
vitro. Infect Immun 1982;35:79-85.
28. Kennedy MJ, Sandin RL. Influence of growth
conditions on Candida albicans adhesion, hydrophobicity
and cell wall ultrastructure. J
Med Vet Mycol 1988; 26: 79-92.
29. Hawser SP, Baillie GS, Douglas J. Production
of extracellular matrix by Candida albicans
biofilms. J Med Microbiol 1998; 47: 253-256.
30. Nikawa H, Nishimura H, Hamada T, Yamashiro
H, Samaranayake LP. Effects of modified
pellicles on Candida biofilm formation on
acrylic surfaces. Mycoses 1999; 42: 37-40.
31. Xu Y, Ambudkar I, Yamagishi H, Swaim W,
Walsh T, Oconneil BC. Histatin 3-mediated
killing of Candida albicans: effect of extracellular
salt concentration on binding and internalization.
Antimicrobial Agents and Chemother
1999; 43: 2256-2262.
32. Branchini ML, Pfaller MA, Rhine-Chalberg J,
Frempong T, Isenberg HD. Genotipic variation
and slime production among blood and catheter
isolates of Candida parapsilosis. J Clin Microbiol
1994; 32: 452-456.
33. Martone JW, Jarwis WR, Edwards JR, Culver
DH, Haley RU. Incidence and nature of endemic
and epidemic nosocomial infections. Hospital
Infectionsda. Ed. Bennet JV, Brachman
PS. 4th ed. Philadelphia, Lippincott, 1998:42-
70.
34. Yüce A, Yücesoy M, Yuluğ N. Detection of slime
production among isolates of Candida albicans.
İnfeksiyon Derg 1996; 10: 267-69.
35. Stulsky B et al. White-opaque transition: a
second high-frequency switching system in
Candida albicans. J Bacteriol 1987; 169: 189-
197.
36. Hellstein J, Vawter-Hugart H, Fotos P, Schmid
J, Soll DR. Genetic similarity and phenotipic
diversity of commensal and pathogenic strains
of Candida albicans isolated from the oral cavity.
J Clin Microbiol 1993; 31: 3190-3199.
37. Soll DR, Langtimm CJ, McDowell J, Hicks J,
Galask R. High-frequency switching in Candida
strains isolated from vaginit patients. J
Clin Microbiol 1987; 25: 1611-1622.
38. Soll DR, Galask R, Isley S, GopalaRao TV,
Stone D, Hicks J, Schmid J, Mac K, Hanna C.
Switching of Candida albicans during successive
episodes of recurrent vaginitis. J Clin Microbiol
1989; 27: 681-690.
39. Odds F. Special report on the Fifth Conference
on Candida and candidiasis. (March 1-4, 1999,
Charleston, USA). Mycology Newsletter 1999;
1: 9-14.
40. Ghannoum MA. Mechanisms potentiating Candida
infection. A review. Mycoses 1988; 31: 543-
557.
Thank you for copying data from http://www.arastirmax.com
